GSK GSK plc
47.02USD+0.90%Mkt Cap: 94.21B $P/E: 14.831d ago
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States…
Industry Peers
Drug Manufacturers - General$1.06TUSDP/E 39.9
LLY
Eli Lilly and Company$1.01TUSDP/E 39.6
$622.84BUSDP/E 29.9
$479.52BUSDP/E 76.7
ABBV
AbbVie Inc.$458.43BUSDP/E 76.9
$335.37BUSDP/E 24.1
$352.29BUSDP/E 113.3
ROP
Roche Holding AG$327.37BUSDP/E 23.5
MRK
Merck & Co., Inc.$351.41BUSDP/E 112.9
ROG
Roche Holding AG$331.80BUSDP/E 21.4
$260.36BUSDP/E 22.9
$272.33BUSDP/E 21.6
$260.71BUSDP/E 25.2
NVS
Novartis AG$266.84BUSDP/E 22.5
$238.84BUSDP/E 25.7
$248.33BUSDP/E 23.9
$223.32BUSDP/E 25.7
$205.33BUSDP/E 24.4
AMGN
Amgen Inc.$217.60BUSDP/E 25.6
$182.09BUSD
Key Statistics
Company
Market Cap94.21B USD
Enterprise Value108.08B USD
Revenue (TTM)33.20B USD
Gross Profit23.65B USD
Net Income (TTM)5.72B USD
Revenue/Share16.51 USD
Last Price47.02 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees66.8K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)14.83
P/E (Forward)9.43
PEG5.66
EV/EBITDA9.99
EV/Revenue3.26
P/S2.81
P/B4.00
EPS (TTM)3.17
EPS (Forward)4.94
52W Range
42.8522% of range61.70
52W High61.70 USD
52W Low42.85 USD
Profitability
Gross Margin72.40%
Oper. Margin30.94%
EBITDA Margin32.58%
Profit Margin17.50%
ROE34.90%
ROA9.35%
Growth
Revenue Growth5.30%
Earnings Growth-69.50%
Cash Flow & Leverage
Operating CF7.74B USD
CapEx (TTM)2.98B USD
FCF Margin10.49%
FCF Yield3.70%
Net Debt15.19B USD
Net Debt/EBITDA1.40
Balance Sheet
Debt/Equity1.08
Current Ratio0.81
Quick Ratio0.52
Book Value/Sh11.65 USD
Cash/Share1.55 USD
Dividends
Fwd Div Rate1.82 USD
Trail. Div Rate0.68 USD
Div. Yield3.90%
5Y Avg Yield4.12%
Payout Ratio56.55%
Ex-Div DateAug 14, 2026
Pay DateOct 8, 2026
Splits
Last Split1226:1000
Split DateJul 22, 2022
Analyst Consensus
Rating2.6 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)59.45 USD
Upside (mean)+26.4%
Target Range49.00 USD – 70.00 USD
49.00+26.4% to mean70.00
# Analysts8
Ownership
Shares Out.2.00B
Float1.94B
Insiders0.06%
Institutions17.47%
Short Interest
Short Ratio5.3d
Short % Float0.73%
Short % Out.0.73%
Shares Short14.65M
Short (prev mo.)14.78M
Technical
SMA 5050.52 (-6.9%)
SMA 20052.41 (-10.3%)
Beta0.28
S&P 52W Chg15.78%
Avg Vol (30d)3.45M
Avg Vol (10d)4.26M
Technical Indicators
RSI (14)35.9
MACD-0.9658
MACD Signal-0.6840
MACD Hist.-0.2818
BB Upper52.02 USD
BB Middle48.99 USD
BB Lower45.97 USD
BB Width12.35%
ATR (14)0.9156 USD
Vol Ratio (20d)1.57x